104That provision has the effect of allowing the procedure for the renewal of approval of the active substance to be extended on account of reasons arising in the course of the procedure itself that were previously unknown. Thus, before the adoption of the contested regulation, it was not certain that the diflubenzuron renewal procedure would end before 31 December 2018 or even before 30 June 2019.